As our data contain potentially identifying and sensitive patient information, the ethics committee of Nawaloka hospital does not allow the data to be shared without permission. If data request is needed, please kindly contact Dr. Wasitha Abeysuriya from the data access committee for this study at <vasithaabey@hotmail.com>.

Introduction {#sec005}
============

Dengue infection (DI) is the most common arthropod-borne virus disease, with 2.5 billion people worldwide, across all age groups, at risk of infection \[[@pone.0215061.ref001]\]. The clinical manifestations of DI are heterogeneous, with the most severe and life-threatening forms being dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS)\[[@pone.0215061.ref002]\]. Between 2001 to 2010, an estimated 5,906 DI related deaths were reported\[[@pone.0215061.ref003]\].

Severe complications of DI occur in only approximately 2--5% of patients, but it is important to be able to identify patients who will develop complications early to assist in effective risk stratification. \[[@pone.0215061.ref004],[@pone.0215061.ref005]\]. Early risk stratification of patients with DI can potentially prevent overburden of the healthcare system by focusing on those who need expert care and those who do not, especially in resource limited countries\[[@pone.0215061.ref006]\]. However, there is currently no validated laboratory test which can predict severe complications of DI. Several clinical parameters have been proposed as predictive factors of severe DI. These include the presence of abdominal pain, vomiting, nausea, hepatomegaly, fluid accumulation, bleeding, respiratory distress, altered mental status and shock\[[@pone.0215061.ref007]\]. However, these clinical parameters can be subjective as they are based on clinical judgement \[[@pone.0215061.ref008]\].

The diagnosis of DI is based on clinical history and laboratory tests. The most widely used diagnostic test for DI is an enzyme linked immunosorbent assay (ELISA) \[[@pone.0215061.ref009]\] which measures dengue Ig M or Ig G antibodies. This test can only be reliably detecting dengue antibodies 3--4 days after the onset of symptoms; hence, false negative results remain a concern. The alternatives are the use of the dengue nonstructural protein 1 (NS1) antigen, which is a glycoprotein necessary for the viability of dengue virus; and the dengue reverse transcriptase PCR (RT-PCR). Although these tests are useful for the diagnosis of DI, they are not useful for the prediction of DI severity \[[@pone.0215061.ref010]\].

The Atypical Lymphocyte count (AL) is a research parameter generated when a Full Blood Count (FBC) is performed on Sysmex automated FBC analyzers. This technology is known to be specific and sensitive for the detection of abnormal white blood cells such as atypical lymphocytes\[[@pone.0215061.ref011]\]. These atypical lymphocytes have an increased nucleic acid percentage and characteristics scatter properties which can be detected by an increase in fluorescence signal\[[@pone.0215061.ref012]\]. During DI progression, it has been observed that affected patients produced atypical lymphocytes seen in the peripheral blood circulation. These atypical lymphocytes have been identified as CD19+ B lymphocytes using flow cytometry\[[@pone.0215061.ref013]\]. It is postulated that these lymphocytes are antibody immune reaction to the dengue virus, which could explain the significant increase in anti-dengue immunoglobulin G (IgG) antibodies during the secondary dengue infection. Recently, atypical plasmacytoid lymphocytes have been described in patients with dengue infection, which similarly correlates to the significant elevation in IgG levels\[[@pone.0215061.ref014]\]. AL has been demonstrated to be useful for the differentiation of DI from other viral infections \[[@pone.0215061.ref011], [@pone.0215061.ref012]\]. Therefore, we seek to assess the association of AL with severity of dengue infection.

Methodology {#sec006}
===========

Study design {#sec007}
------------

We conducted a prospective observational cohort study on adult patients admitted to Nawaloka Hospital Sri Lanka (NH) with DI between 2016 December and 2017 November.

Ethical approval {#sec008}
----------------

Ethical approval for this study was obtained from the Ethics Review Committee, Faculty of Medicine, and University of Colombo. All patients provided informed consent for their data to be included in the study.

Study population {#sec009}
----------------

530 patients aged 18 to 80 years with DI confirmed by a positive NS1 antigen and/or positive dengue immunoglobulin M (Dengue IgM) ELISA (enzyme linked immunosorbent assay; CE-CTK biotech test kits) were included in this study. Patients with a known history of hematologic malignancy, immunosuppression, HIV positive status, known infection with other viral pathogens were excluded.

Data collection {#sec010}
---------------

AL data were extracted from the Sysmex XS500i automated FBC analyzer (Sysmex Kobe Japan) on the first full blood count (FBC) drawn as part of the patients' routine investigations. Clinical parameters including presenting symptoms, vital signs, results of other blood investigations and clinical progress (specifically the development of severe DI) were recorded by a study team member during the patients' admission.

We categories dengue fever according to the 2009 WHO criteria classify dengue according to levels of severity: (A) dengue without warning signs; (B) dengue with warning signs (abdominal pain, persistent vomiting, fluid accumulation, mucosal bleeding, lethargy, liver enlargement, increasing hematocrit with decreasing platelets); and (C) severe dengue (dengue with severe plasma leakage, severe bleeding, or organ failure) \[[@pone.0215061.ref007]\].

Data analysis {#sec011}
-------------

Data were entered into EXCEL worksheets and checked manually and corrected where necessary. Descriptive statistics were derived and expressed as measures of central tendency and frequencies. Hence, Atypical Lymphocyte % distribute normally P-values obtain through student t-test was used to compare averages between two groups. ANOVA was used to compare mean values of more than two groups. The predictive cutoff value was obtained through Receiver Operating Characteristics (ROC) curve analysis. Data were analyzed using the Statistical Package for Social Sciences 16 (SPSS) (SPSS 16.0, Chicago, Illinois, USA) and STATA version 12 (12.0, Texas, USA). P values of \<0.05 were considered significant.

Results {#sec012}
=======

[Table 1](#pone.0215061.t001){ref-type="table"} shows the socio-demographic characteristics of study population. 52.5% of patients were female. The median age was 34 years. 77.9% did not have any co-morbidity. 43.7% of the patients were admitted to hospital following two days of fever, while 84.3% were admitted after four days of fever. Confirmation of DI was based on positive Dengue NS1 (81.1%), Dengue IgM (16.9%) and both (2.0%). The percentage of patients who suffered from severe dengue is 1.32%.

10.1371/journal.pone.0215061.t001

###### Socio demographic characteristics of study population.

![](pone.0215061.t001){#pone.0215061.t001g}

  Variable                         Number   Percentage %
  -------------------------------- -------- --------------
  **Age (In years)**                        
  Less than 20                     42       7.9
  21 to 40                         278      52.4
  41 to 60                         175      33.0
  Above 61                         35       6.7
  **Sex**                                   
  Female                           278      52.5
  Male                             252      47.5
  **Co-morbidity**                          
  None                             413      77.9
  Diabetes                         23       4.3
  Hypertension                     30       5.6
  Hyperlipidemia                   36       6.9
  Other                            27       5.3
  **Days of fever on admission**            
  Less than 2                      232      43.7
  3 to 4                           217      40.6
  5 to 6                           55       10.4
  More than 7                      26       5.3
  **Confirmation of Dengue**                
  Dengue NS1 Positive              430      81.1
  Dengue IgM Positive              90       16.9
  Both Positive                    10       2.0

The mean total white cell count of the study population was 4.12±2.1 ((х10^9^). Mean (SD) Atypical Lymphocyte Count (ALC) (х10^3^), Atypical Lymphocyte percentage (AL %) and Platelet count (х10^9^) of the cohort were 0.1±0.3, 2.35±4.7 and 83.1±56.9 respectively.

[Table 2](#pone.0215061.t002){ref-type="table"} shows the parameters of severity of DI among the study population. Patients who presented with respiratory compromise (oxygen saturation less than 95%) had statistically significantly higher AL% compared to those without. (AL%; 8.65±12.09 vs 2.17±4.25 \[p = 0.01\]). Similarly, patients who developed hypotension (mean arterial pressure less than 65mmHg) had higher AL% compared to those who did not suffered from shock (AL%; 8.40±1.26 vs 2.18±4.25 \[p = 0.001\]). The AL% of dengue patients presenting with bleeding, at 4.07%, is also higher than those without bleeding complications, at 2.15%. There were no deaths reported among the study population.

10.1371/journal.pone.0215061.t002

###### Parameters of severity of dengue fever among the study population.

![](pone.0215061.t002){#pone.0215061.t002g}

  Variable                                                                              Number (%)   Atypical Lymphocyte %   P Value[\*](#t002fn001){ref-type="table-fn"}
  ------------------------------------------------------------------------------------- ------------ ----------------------- ----------------------------------------------
  **Presence of abdominal pain and tender**                                                                                  
  No                                                                                    411 (77.6)   1.97±3.89               0.18[\*](#t002fn001){ref-type="table-fn"}
  Yes                                                                                   119 (22.4)   2.87±5.24               
  **Presence of hepatomegaly of more than 2cm**                                                                              
  No                                                                                    516 (97.4)   2.23±4.31               0.16[\*](#t002fn001){ref-type="table-fn"}
  Yes                                                                                   14 (2.6)     2.24±2.31               
  **Persistent vomiting despite symptomatic treatment**                                                                      
  No                                                                                    515 (97.2)   2.21±4.23               0.81[\*](#t002fn001){ref-type="table-fn"}
  Yes                                                                                   15 (2.8)     1.27±1.30               
  **Aspartate transaminase (AST) and Alanine transaminase (ALT) more than 1000 IU/L**                                        
  No                                                                                    526 (99.3)   2.06±4.68               0.78[\*](#t002fn001){ref-type="table-fn"}
  Yes                                                                                   4 (0.7)      2.50±4.77               
  **Presence of respiratory compromise (Oxygen saturation less than 95%)**                                                   
  No                                                                                    517 (97.6)   2.17±4.25               0.01[\*](#t002fn001){ref-type="table-fn"}
  Yes                                                                                   13 (2.4)     8.65±12.09              
  **Presence of Shock (Mean arterial pressure less than 65mmHg)**                                                            
  No                                                                                    526 (99.3)   2.18±4.25               0.001[\*](#t002fn001){ref-type="table-fn"}
  Yes                                                                                   4 (0.7)      8.40±1.26               
  **Presence of Bleeding**                                                                                                   
  No                                                                                    523 (98.7)   2.15±4.22               0.02[\*](#t002fn001){ref-type="table-fn"}
  Yes                                                                                   7 (1.3)      4.07±5.79               

\*Based on Mann-Whitney U Test

[Table 3](#pone.0215061.t003){ref-type="table"} shows the association between AL % with dengue without warning signs, with warning signs and severe dengue. Based on ANOVA analysis there was statically significant association between three groups (p = 0.001). The highest mean AL% was reported in the severe dengue group (AL%:10.8±3.31).

10.1371/journal.pone.0215061.t003

###### Association between atypical lymphocyte percent with dengue without warning signs, with warning signs and sever dengue.

![](pone.0215061.t003){#pone.0215061.t003g}

  -------------------------------------------------------------------------------------------------------------------------------------------------
  Classification                 Number (%)   Atypical lymphocyte %                              Significant[\*](#t003fn001){ref-type="table-fn"}
  ------------------------------ ------------ -------------------------------------------------- --------------------------------------------------
  Dengue without warning signs   364 (68.6)   1.59[^a^](#t003fn002){ref-type="table-fn"}±1.36    P = 0.001\
                                                                                                 F = 41.84\
                                                                                                 df = 2

  Dengue with warning signs      152(28.6)    4.47[^b^](#t003fn002){ref-type="table-fn"}±1.56    

  Severe dengue                  14(2.8)      10.80[^c^](#t003fn002){ref-type="table-fn"}±3.31   
  -------------------------------------------------------------------------------------------------------------------------------------------------

\*Based on ANOVA and

^a,\ b\ and\ c^ Post hoc test (Tukey HSD)

Association between AL % with severe dengue and non-severe dengue (with/without warning sings) shows in [Table 4](#pone.0215061.t004){ref-type="table"}. Based on t-test there was a significant association between two groups. (p = 0.001).

10.1371/journal.pone.0215061.t004

###### Association between atypical lymphocyte % with severe dengue and non-severe dengue (with/without warning signs).

![](pone.0215061.t004){#pone.0215061.t004g}

  Classification      Number (%)   Atypical lymphocyte %   Significant[\*](#t004fn001){ref-type="table-fn"}
  ------------------- ------------ ----------------------- --------------------------------------------------
  Severe dengue       14(2.8)      10.80±3.31              P = 0.001
  Non-severe dengue   516(97.2)    2.17± 1.91              

\*Based on student t-test

[Table 5](#pone.0215061.t005){ref-type="table"} shows the association between AL% and mean platelet count (10^9^). Based on ANOVA analysis there was a significant association between AL % categories and mean platelet count (p = 0.04).

10.1371/journal.pone.0215061.t005

###### Association between AL% and mean platelet count (10^9^).

![](pone.0215061.t005){#pone.0215061.t005g}

  ---------------------------------------------------------------------------------------------------------
  AL % Category   Number (%)   Platelet count (10^9^)\   Significant[\*](#t005fn001){ref-type="table-fn"}
                               Mean±SD                   
  --------------- ------------ ------------------------- --------------------------------------------------
  Below 10        451(85.1)    83.6±47.6                 P = 0.04\
                                                         F = 4.121\
                                                         df = 2

  11 to 20        55(10.3)     52.3±31.6                 

  Above 21        24(4.6)      47.9±18.1                 
  ---------------------------------------------------------------------------------------------------------

\*Based on ANOVA test

[Fig 1](#pone.0215061.g001){ref-type="fig"} show the Receiver Operating Characteristics (ROC) curve analysis of AL% more than 0.55% was predictive cutoff values for severe dengue fever during the disease progression. It has 95.5% sensitivity and 71.5% specificity.

![Atypical lymphocyte % more than 0.55 use as a predictive cutoff value to suspect severe dengue cases during the disease progression.\
(AUC = 87.2% \[95%CI = 73%-93.4%\]).](pone.0215061.g001){#pone.0215061.g001}

Based on the Pearson correlation coefficient there was a negative correlation between platelet count and AL%, as well as ALC (×10^3^). (Pearson Correlation = -0.116 \[p = 0.017\] and Pearson Correlation = -0.130 \[p = 0.008\]). But R square in the diagrams show only 0.014 and 0.017. (Figs [2](#pone.0215061.g002){ref-type="fig"} and [3](#pone.0215061.g003){ref-type="fig"}).

![The correlation between platelet count and absolut atypical lymphocyte count (×10^3^).](pone.0215061.g002){#pone.0215061.g002}

![The correlation between platelet count and atypical lymphocyte %.](pone.0215061.g003){#pone.0215061.g003}

Discussion {#sec013}
==========

We showed that patients with clinical manifestations of severe dengue have a significantly higher AL % compared to dengue without warning signs. Similarly, the AL % among those with respiratory compromise, hypotension and bleeding symptoms is higher as compared to those without. These results suggest that a higher AL % level is associated with increased complications of dengue infection, leading to severe dengue. From Tables [3](#pone.0215061.t003){ref-type="table"} and [4](#pone.0215061.t004){ref-type="table"}, it is evident that patients with severe dengue infection, have significantly more AL % in their peripheral blood, compared to DI without warning signs. In addition, there is a statistically significant 5-fold difference in AL % between severe and non-severe DI. From subgroup analysis between DI with and without warning signs in [Table 3](#pone.0215061.t003){ref-type="table"}, there is a positive association of AL % with severity of DI. The predictive cut-off AL % value for predicting severe DI is \> 0.55, as shown in [Fig 1](#pone.0215061.g001){ref-type="fig"}, with the sensitivity of 95.5% and specificity of 71.5%. For our study, this is a point estimate which limits its predictive value, therefore, it is likely that consecutive measurements may improve on this and future studies would be required. This is clinically relevant as this may be used as a simple and dynamic predictive measurement for DI severity.

In a study done on the hematological parameters of 138 Indonesian patients, flow cytometry was used to differentiate between DI, leptospirosis and enteric fever. Patients with DI were found to have a higher percentage of AL, when compared to patients with enteric fever and leptospirosis infections \[[@pone.0215061.ref015]\]. In another study which analyzed the immunophenotypes of lymphocytes in 100 patients with DI of different severity, such as DHF, dengue fever (DF) and dengue like syndrome (DLS), it was concluded that the mean total atypical lymphocytes in DHF and DF were higher than those of DLS\[[@pone.0215061.ref013]\]. In a recent 2017 study done by Anagha et al \[[@pone.0215061.ref016]\], they showed that atypical lymphocytes count does predict the severity of thrombocytopenia for DI and this contributes to the severity of dengue. However, this study and other previous similar studies did not investigate the association of AL % with DI clinical parameters such as respiratory failure, shock and bleeding as well as analyze the predictive cut off AL % value for severe DI, which our study did address.

As mentioned earlier, the most critical period of DI is 3--7 days after the onset of the first non-specific symptoms as this is the period where patients develop severe DI complications \[[@pone.0215061.ref017]\]. Due to the lack of reliable predictive tests, patients with severe DI are at risk of delays in appropriate management, since the majority of DI patients are treated conservatively in outpatient setting. However, if more objective measurements such as AL % can be used to identify these patients, they can be placed on closer monitoring and encouraged for aggressive hydration if early warning signs of severe dengue are present\[[@pone.0215061.ref018]\].

The increase in AL % is associated with the decrease in platelet count as shown in [Table 5](#pone.0215061.t005){ref-type="table"} and [Fig 3](#pone.0215061.g003){ref-type="fig"}. The analysis of platelet count and AL% has shown that there is an inverse relationship between the two variables, with the correlation coefficient of -0.116. From [Table 5](#pone.0215061.t005){ref-type="table"}, it also demonstrated that with the circulating AL % being more than 20% in the peripheral blood, the mean platelet count could fall below 50 x 10^9^. This may be the explanation for the increase in bleeding complications among dengue patients with higher AL% as demonstrated in [Table 2](#pone.0215061.t002){ref-type="table"}. Thrombocytopenia related to DI is thought to be at least partly immune mediated \[[@pone.0215061.ref019]\]. It is reasonable to speculate whether the high AL reflects greater immune dysregulation resulting in more severe thrombocytopenia. The same maybe said of the more severe complications of DI. These are important areas to be addressed by future research studies as immunosuppressive therapy such as steroids may warrant evaluation in clinical trials for such patients.

Our study has several limitations. The study population was taken from a single centre in Sri Lanka, therefore the results should be extrapolated with caution to different geographic areas as patients may have a different genetic background, and endemic dengue virus serotypes may differ. Both factors are not controlled for within this study. The population sample data was obtained at different phase of infection and the study has a relatively small number of patients with severe DI. Therefore, these results can be analyzed as a point estimate of the association of AL and severity of DI. This can be improved for future studies by serial analysis of a patient's FBC throughout the period of DI, from presentation to recovery, as well as include FBC analysis from healthy participants as the control of the study. The Sysmex XS500i automated FBC analyzer may not be readily available in all laboratories in all developing countries, hence, using AL to predict dengue severity may be limited to some institutions. However, we hope that through this study, it demonstrates that routinely performed blood investigations such as full blood count can be used to assess the severity of dengue infection, thus, appealing to a wider audience to participate in using simple and cost-effective measurements for further analysis.

Conclusions {#sec014}
===========

Clinical manifestations of severe dengue have a significantly higher AL % compared to dengue without warning signs. AL % at presentation may be predictive of severe DI and future larger prospective longitudinal studies should be done to determine if AL % on admission is predictive of the complications of DI later in the course of dengue infection.
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